« Return to News | CROs/Service Providers | Technology Solutions

i3 Streamlines Clinical Trial Management With New Technology

Wednesday, March 18, 2009 09:18 AM

Contract research organization (CRO) i3 launched a new web-based clinical trial and data management program that will replace the need for multiple systems and applications to manage study activities.

The new technology, i3Cube, centralizes study information into a single location throughout the entire clinical trial process, providing sponsors and investigative site staff with real-time reporting and access to study information. The study team can access the information at any time by logging into a secure web portal.

According to a company release, i3Cube accelerates the data management process by streamlining communication across the entire study team, automating workflow and providing an integrated study library with version control, including an electronic trial master file.

“i3Cube was designed to provide our clients and clinical investigators with a simple, easy-to-use, and streamlined experience,” said i3 CEO Glenn Bilawsky in an i3 statement. “We brought together our use of proprietary health care claims data with our clinical research expertise and developed i3Cube to create time and cost efficiencies for our customers.” 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.